期刊文献+

小鼠Ii分子的克隆表达及在COS-7细胞中的亚细胞定位 被引量:1

Expression and localization of BALB/c mouse invariant chain in COS-7 cell line
原文传递
导出
摘要 目的获取BALB/c小鼠Ii链编码基因,构建真核表达载体并在真核细胞中表达。方法RT-PCR获取BALB/c小鼠Ii链编码基因,插入pEGFP真核表达载体,脂质体转染COS-7细胞,荧光显微镜和激光共聚焦观察外源基因的表达。结果外源基因在COS-7细胞中得到高效表达,激光共聚焦的结果显示,外源基因定位在细胞的内膜系统,并能够和I-Ad分子形成聚集体。结论Ii链在真核细胞中表达后定位在细胞的内膜系统并能和I-Ad分子形成聚集体。 Objective To get Ii chain encoding region, and construct a eukaryotic expression vector, that express efficiently in Mammalia cell line. Methods The encoding gene of BALB/c mouse was obtained by RT-PCR method, then the gene segments were inserted into pEGFP vector. COS-7 cell line was transfected by Li- pofectAMINE2(DO. The expression of foreign gene was demonstrated by laser focus confocal microscope (LFCM). Results The foreign gene was efficiently expressed in COS-7 cell line. The LFCM results indicated the expressed protein localized in inner membrane system. It could assemble with I-A^d molecular after synthesis. Conclusion Ii encoding gene could express efficiently in Mammalia cell line and assemble with I-A^d molecular after synthesis.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2006年第6期481-483,共3页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30200245)
关键词 BALB/C小鼠 恒定链 真核表达 MHCⅡ BALB/c mouse Invariant chain Eukaryotic expression MHCⅡ
  • 相关文献

参考文献8

  • 1Ertolino P,Babourdin-Combe C.The MHC class Ⅱ -associated invariant chain:A molecular with multiple roles in MHC class Ⅱ biosynthesis and antigen presentation to CD4+ T cells.Critical Reviews Immul,1996,16:359-379.
  • 2Kropshofer H,Vogt AB,Stem LJ,et al.Self-release of CLIP in peptide loading of HLA-DR molecules.Science,1995,270(5240):1357-1359.
  • 3高明,王海平,王燕宁,周勇,王全立.BALB/c小鼠I-A^dαβ链RFP融合双顺反子表达载体的构建及其在COS-7中的表达[J].生物技术通讯,2004,15(6):546-548. 被引量:3
  • 4高明,王海平,王全立.Ⅱ类抗原提呈的分子机制及分子伴侣Ii研究进展[J].微生物学免疫学进展,2004,32(4):70-72. 被引量:3
  • 5Stumptner-Cuvelette P,Benaroch P.Multiple roles of the invariant chainin MHC class Ⅱ fuction.Biochim Biophys Acta,2002,1542(1-3):1-13.
  • 6Bischof F,Wienhold W,Wirblich C,et al.Specific treatment of autoimmunity with recombinant invariant chain in which CLIP is replaced by self-epitopes.Proc Natl Acad Sci USA,2001,98(21):12168-12173.
  • 7van Tienhoven EA,ten Brink CT,van Bergen J,et al.Induction of antigen specific CD4^+ T cell responses by invariant chain based DNA vaccines.Vaccine,2001,19(11-12):1515-1519.
  • 8Nagata T,Higashi T,Aoshi T,et al.Immunization with plasmid DNA encoding MHC class Ⅱ binding peptide/CLIP-replaced invariant chain (Ii) induces apecific helper T cells in vivo:the assessment of Ii p31 and p41 isoforms as vehicles for immunization.Vaccine,2001,20(1-2):105-114.

二级参考文献22

  • 1van Tienhoven EA, ten Brink CT, van Bergen J,et al. Induction of antigen specific CD4+T cell responses by invariant chain based DNA vaccines[J]. Vaccine 2001,19 (11-12):1515-1519.
  • 2Ji H, Chang EY, Lin KY, et al. Antigen-specific immunotherapy for murine lung metastatictumors expressing human papillomavirus type 16 E7 oncoprotein[J]. Int J Cancer 1998,78(1):41-45.
  • 3Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity[J]. Immunol Today 1998,19(10):448-454.
  • 4Felix B, Wolfgang W,Christoph W,et al. Specific treatment of autoimmunity with recombinant invariant chain in which CLIP is replaced by self-epitopes[J]. Proc Natl Acad Sci USA 2001,98:12168-12173.
  • 5Moingeon P. Strategies for designing vaccines eliciting Thl responses in humans[J].Journal of Biotechnology 2002,98:189-198.
  • 6Moingeon P, Haensler J, Lindberg A.Towards the rational design of Thl adjuvants[J].Vaccine 2001,19:4363-4372.
  • 7Rengarajan J, Szabo SJ, Glimcher LH.Transcriptional regulation of Thl/Th2 polarization[J].Immunology Today 2000,21:479-483.
  • 8Rovere P, Zimmermann VS, Forquet F, et al. Dendritic cell maturation and antigen presentation in the absence of invariant chain[J]. Proc Natl Acad Sci USA 1998,95(3): 1067-1072.
  • 9Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class Ⅱ presentation of tumor antigen[J].Cancer Res 1996,56 (1):21-26.
  • 10Malcherek G, Wirblich C, Willcox N, et al. MHC class Ⅱ-associated invariant chain peptide replacement by T cell epitopes:engineered invariant chain as a vehicle for directed and enhanced MHC class Ⅱ antigen processing and presentation[J]. Eur J Immunol

共引文献4

同被引文献5

  • 1高明,王海平,王燕宁,周勇,王全立.BALB/c小鼠I-A^dαβ链RFP融合双顺反子表达载体的构建及其在COS-7中的表达[J].生物技术通讯,2004,15(6):546-548. 被引量:3
  • 2高明,王海平,王燕宁,周勇,王全立.BALB/c小鼠I-A^dαβ链和恒定链Ii在COS-7中的共定位[J].军事医学科学院院刊,2004,28(6):505-508. 被引量:2
  • 3van Tienhoven EA,ten Brink CT,van Bergen J,et al.Induction of antigen specific CD4+T cell responses by invariant chain based DNA vaccines.Vaccine,2001,19:1515-1519.
  • 4Nagata T,Higashi T,Aoshi T,et al.Immunization with plasmid DNA encoding MHC class Ⅱ binding peptide/CLIP-replaced invariant chain(Ii)induces specific helper T cells in vivo:the assessmentof Ii p31 and p41 isoforms as vehicles for immunization.Vaccine,2001,20:105-114.
  • 5Yu H,Huang H,Xiang J,et al.Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.J Gen Virol,2006,87 Pt 1:1-10.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部